| Cases | Age at diagnosis (years); sex | Histologic diagnosis; tumor location | Prior surgery | Prior therapy | Age on treatment onset (years) | Time on treatment (months) | Best overall response | Functional response | Side effects |
|-------|-----------------------------|-------------------------------------|---------------|--------------|-----------------------------|-------------------------|------------------------|---------------------|-------------|
| Case 1 | 1.5; F                      | PA; medulla oblongata with leptomeningeal dissemination | Biopsy        | CPT 11-CDDP; VBL | 5.8                          | 20                      | PR                     | Stable              | Skin (grade II) Abdominal pain (grade II) Cheilitis (grade I) CPK and AP increased (grade I) Skin (grade I) Cheilitis (grade I) Skin (grade II) Alopecia (grade I) Vasculitis (grade III) CPK and ALT increased (grade I) Skin (grade II) Cheilitis (grade I) Mucositis oral (grade I) Abdominal pain (grade I) Fatigue and anorexia (grade II) CPK increased (grade I) Alopecia (grade II) Cheilitis (grade III) Mucositis oral (grade II) Fatigue and anorexia (grade II) Skin (grade I) Alopecia (grade I) Mucositis oral (grade I) CPK and LDH increased (grade I) Skin (grade II) Alopecia (grade I) Abdominal pain (grade I) Skin (grade I) | |
| Case 2 | 0.5; M                      | PMA; hypothalamic-chiasmatic        | Biopsy, PR    | VCR-CBCDA; 5 DR-BEV | 1                            | 18                      | SD                     | Stable              | |
| Case 3 | 0.9; F                      | PA; intramedullary                 | Biopsy        | VCR-CBCDA; CPT 11-CDDP | 12                           | 15                      | SD                     | Improvement of brachial hemiparesis, resolution of paresthesia in hands and torticollis | |
| Case 4 | 1; M                        | PMA; hypothalamic-chiasmatic       | Biopsy        | CPT 11-CDDP; VBL; BEV-CDDP | 7.5                          | 5                       | SD                     | Stable              | |
| Case 5 | 4.4; F                      | PA; hypothalamic-chiasmatic        | Biopsy, PR    | CPT 11-CDDP; VBL; BEV-CDDP | 12.5                         | 8                       | PD                     | Visual deterioration | |
| Case 6 | 5.8; F                      | PA; intramedullary                 | Biopsy, PR    | CPT 11-CDDP; VBL; BEV-CDDP | 12.3                         | 15                      | SD                     | Resolution of paresthesia in hands | |
| Case 7 | 0.8; F                      | PMA; hypothalamic-chiasmatic       | Biopsy        | VCR-CBCDA; BEV | 2.8                          | 6                       | PD                     | Stable              | |
| Case 8 | 1.8; M                      | PAs; hypothalamic-chiasmatic       | Biopsy        | VCR-CBCDA; VBL | 2.9                          | 6                       | PD                     | Increased hemiparesis and cranial nerve abnormalities | |
| Case 9 | 3.9; M                      | PA; hypothalamic-chiasmatic with leptomeningeal dissemination | PR            | CPT 11-CDDP | 9.6                          | 14 (continue)           | SD                     | Stable              | |
| Case 10| 0.4; M                      | PMA; hypothalamic-chiasmatic       | Biopsy, PR    | VCR-CBCDA; VBL-BEV | 1.8                          | 14 (continue)           | SD                     | Diencephalic syndrome improvement | |
| Case 11| 1.3; F                      | GG; intramedullary                | Biopsy, PR    | CPT 11-CDDP; VBL; VCR-CBCDA; BEV-CPT 11 | 10.8                         | 12 (continue)           | SD                     | Stable              | |

Plagga with KJAA1549-BRAF fusion: patient characteristics, response, and toxicity with trametinib.